Avance Biosciences™ licenses SeQure Dx’s GUIDE-seq off-target NGS analysis technology
webmaster2024-08-09T18:08:43+00:00Avance Biosciences™ (Avance), a leading CRO that provides GLP/CGMP-compliant biological testing services that aid drug development and manufacturing, announced today that it has signed a licensing agreement with SeQure Dx, a cutting-edge gene-editing diagnostics company...